Clinical relevance of mutant-allele tumor heterogeneity and lung adenocarcinoma

被引:18
|
作者
Mao, Hengyu [1 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Thorac Surg, 270 Dong An Rd, Shanghai 200032, Peoples R China
关键词
Prognosis; non-small cell lung cancer (NSCLC); mutant-allele tumor heterogeneity (MATH); INTRATUMOR GENETIC-HETEROGENEITY; CLONAL EVOLUTION; CANCER; HEAD;
D O I
10.21037/atm.2019.08.112
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Intra-tumor heterogeneity (ITH) plays an important role in the progressing of lung adenocarcinoma (LUAD). We used a mutant-allele tumor heterogeneity (MATH) algorithm to measure ITH and the correlation between ITH and clinical parameters and its prognosis. Methods: We assessed 230 LUAD patients from The Cancer Genome Atlas (TCGA). We calculated the MATH values from whole-exome sequencing data and further investigated their correlation with clinical characteristics. Results: The patients were divided into low and high MATH groups. People with high MATH were more likely to be female, smoking and EGFR mutation. And a high MATH may predict a poor prognosis. Conclusions: MATH is a new method for describing the internal heterogeneity of tumors in lung cancer. We used TCGA data to demonstrate that groups with higher MATH values are more likely to be female, smoker and EGFR mutations, and may have a poor prognosis.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer
    Ding Ma
    Yi-Zhou Jiang
    Xi-Yu Liu
    Yi-Rong Liu
    Zhi-Ming Shao
    [J]. Breast Cancer Research and Treatment, 2017, 162 : 39 - 48
  • [2] Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer
    Ma, Ding
    Jiang, Yi-Zhou
    Liu, Xi-Yu
    Liu, Yi-Rong
    Shao, Zhi-Ming
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 162 (01) : 39 - 48
  • [3] Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung Adenocarcinoma
    Wu, Xiaoxuan
    Song, Peng
    Guo, Lei
    Ying, Jianming
    Li, Wenbin
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Mutant-Allele Tumor Heterogeneity Scores Correlate With Risk of Metastases in Colon Cancer
    Rajput, Ashwani
    Bocklage, Therese
    Greenbaum, Alissa
    Lee, Ji-Hyun
    Ness, Scott A.
    [J]. CLINICAL COLORECTAL CANCER, 2017, 16 (03) : E165 - E170
  • [5] Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma
    Hou, Yufang
    Li, Tiegang
    Gan, Wenqiang
    Lv, Silin
    Zeng, Zifan
    Yan, Zheng
    Wang, Weiqi
    Yang, Min
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [6] Mutant-Allele Tumor Heterogeneity (MATH) Scores Correlate with Stage of Colon Cancer
    Rajput, A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S92 - S92
  • [7] Mutant-allele tumor heterogeneity in malignant glioma effectively predicts neoplastic recurrence
    Wu, Pengfei
    Yang, Wei
    Ma, Jianxing
    Zhang, Jingyu
    Liao, Maojun
    Xu, Lunshan
    Xu, Minhui
    Yi, Liang
    [J]. ONCOLOGY LETTERS, 2019, 18 (06) : 6108 - 6116
  • [8] Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis
    Yuying Han
    Xu Liu
    Haihong Ye
    Ye Tian
    Zhengguo Ji
    [J]. World Journal of Surgical Oncology, 18
  • [9] Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis
    Han, Yuying
    Liu, Xu
    Ye, Haihong
    Tian, Ye
    Ji, Zhengguo
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [10] Mutant-allele fraction heterogeneity is associated with non-small cell lung cancer patient survival
    Shen, Sipeng
    Wei, Yongyue
    Zhang, Ruyang
    Du, Mulong
    Duan, Weiwei
    Yang, Sheng
    Zhao, Yang
    Christiani, David C.
    Chen, Feng
    [J]. ONCOLOGY LETTERS, 2018, 15 (01) : 795 - 802